CoChat

Analysis of Promoter CpG Island Hypermethylation in Cancer: Location, Location, Location!

Open access
van Vlodrop, Iris J.H., Niessen, Hanneke E.C., Derks, Sarah, Baldewijns, Marcella M.L.L., van Criekinge, Wim, Herman, James G., van Engeland, Manon · 2011 · Clinical Cancer Research
Cited by 144

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

The genetic and epigenetic alterations that underlie cancer pathogenesis are rapidly being identified. This provides novel insights in tumor biology as well as in potential cancer biomarkers. The somatic mutations in cancer genes that have been implemented in clinical practice are well defined and very specific. For epigenetic alterations, and more specifically aberrant methylation of promoter CpG islands, evidence is emerging that these markers could be used for the early detection of cancer as well as prediction of prognosis and response to therapy. However, the exact location of biologically and clinically relevant hypermethylation has not been identified for the majority of methylation markers. The most widely used approaches to analyze DNA methylation are based on primer- and probe-based assays that provide information for a limited number of CpG dinucleotides and thus for only part of the information available in a given CpG island. Validation of the current data and implementation of hypermethylation markers in clinical practice require a more comprehensive and critical evaluation of DNA methylation and limitations of the techniques currently used in methylation marker research. Here, we discuss the emerging evidence on the importance of the location of CpG dinucleotide hypermethylation in relation to gene expression and associations with clinicopathologic characteristics in cancer. Clin Cancer Res; 17(13); 4225–31. ©2011 AACR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/1078-0432.ccr-10-3394

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 144

Metadata

Authors
van Vlodrop, I. J. H., Niessen, H. E. C., Derks, S., Baldewijns, M. M. L. L., van Criekinge, W., Herman, J. G., & van Engeland, M.
Venue
Clinical Cancer Research
Published
2011-07-01
Volume
17
Issue
13
Pages
4225-4231
ISSN
  • 1078-0432 (ISSN-L)
  • 1557-3265
OpenAlex
W2121278687
Cited by
144
References
10
FWCI
6.00
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Analysis of Promoter CpG Island Hypermethylation in Cancer: Location, Location, Location! https://app.cochat.ai/papers/10.1158/1078-0432.ccr-10-3394
The paper
van Vlodrop, I. J. H., Niessen, H. E. C., Derks, S., Baldewijns, M. M. L. L., van Criekinge, W., Herman, J. G., & van Engeland, M. (2011). Analysis of Promoter CpG Island Hypermethylation in Cancer: Location, Location, Location! Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-10-3394

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.